Maintaining your independence in biotechnology
Mergers and acquisitions are regular events for biotechnology companies. I have often been asked if being acquired is a goal […]
Mergers and acquisitions are regular events for biotechnology companies. I have often been asked if being acquired is a goal […]
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Patient access to innovation: Biopharmaceuticals, 4th hurdles and socioeconomic issues
Go to paperABSTRACT: Biopharmaceuticals and innovative therapeutic…
Patient access to innovation: Biopharmaceuticals, 4th hurdles and socioeconomic issues Read Post »
I will be giving a talk on September 10th at George Washington University on two recent data analytics projects: Firstly,
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Media coverage and biotechnology IPOs: Some Australian evidence
Go to paperABSTRACT: This paper analyses Australian biotechnology initial public offerin…
Media coverage and biotechnology IPOs: Some Australian evidence Read Post »
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Transfer to Africa of the resources and rewards from biotechnology: The need for a participatory approach
Go to paperABSTRACT: The low adoption rate of n…
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
The DNA/RNA market to 2010
Go to paperABSTRACT: The DNA/RNA market is currently at an early stage of development, with only two marketed products that t…
This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post?
Biotechnology in Countries Starting with "I" – Part 6: Iceland Read Post »
This is a guest post from Isabela Oliva. Do you have a response to Isabela’s post? Respond in the comments section
This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Solid organ xenotransplantation: Progress, promise and regulatory issues
Go to paperABSTRACT: Xenotransplantation, the process of transplanting live cel…
Solid organ xenotransplantation: Progress, promise and regulatory issues Read Post »
This is a guest post from Zhen-Xia Chen. Do you have a response to Zhen-Xia’s post? Respond in the comments
Get new actionable insights and updates from BiotechBlog